Viewing Study NCT02076620

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-01-17 @ 1:06 AM
Study NCT ID: NCT02076620
Status: COMPLETED
Last Update Posted: 2022-04-04
First Post: 2014-02-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Sponsor: Philogen S.p.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors Amenable to Anthracycline Therapy View
None Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None L19 View
None monoclonal View
None antibody View
None doxorubicin View
None TNFα View
None solid tumour View
None sarcoma, breast cancer, lung carcinomas, gynecological cancer View
None anthracycline View